Table 3 Twelve variants identified for association with eGFR-decline using LMM age model RI&RS in the UKB 350K dataset

From: Analyzing longitudinal trait trajectories using GWAS identifies genetic variants for kidney function decline

   

UKB 350K

UKB 150K

UKB 150K

CKDGen (Gorski et al.)

age model RI&RS

age model RI&RS

difference model

difference model

SNPID

Locus

EA

betadecline

Pdecline

betadecline

Pdecline

betadecline

Pdecline

betadeclinea

Pdecline

Identified variants that were known for eGFR-decline (directly or per proxy with r2 > 0.8), Pdecline < 0.05/595

rs77924615

UMOD/PDILT

G

−0.060

1.1E − 54

−0.059

2.2E − 32

−0.057

2.2E − 10

−0.074

5.3E − 38

rs13334589

UMOD/PDILT

A

−0.054

1.1E − 42

−0.055

1.0E − 26

−0.060

3.8E − 11

−0.066

2.1E − 31

rs434215

TPPP

A

−0.026

4.3E − 12

−0.024

1.1E − 06

−0.013

0.14

−0.020

3.7E − 04

rs28857283

C15orf54

G

−0.019

3.8E − 09

−0.021

3.8E − 07

−0.022

0.0026

−0.021

1.5E − 06

rs4930319

OVOL1

C

−0.014

1.3E − 05

−0.012

0.0032

−0.013

0.090

−0.015

9.9E − 04

rs10224002

PRKAG2

G

−0.014

2.9E − 05

−0.017

1.2E − 04

−0.019

0.015

−0.020

7.0E − 05

rs1458038

FGF5

C

−0.014

5.3E − 05

−0.015

7.5E − 04

−0.014

0.068

−0.019

3.9E − 05

Identified variants that were novel for eGFR-decline, Pdecline < 0.05/595

rs74209810

UMOD/PDILT

T

−0.032

6.6E − 11

−0.031

9.4E − 07

−0.035

0.0022

−0.017

0.028

rs2783971

SDCCAG8

A

−0.018

1.1E − 08

−0.019

2.9E − 06

−0.021

0.0035

−0.005

0.21

rs854922

RRAGD

A

−0.024

7.5E − 06

−0.026

2.7E − 04

−0.022

0.073

0.006

0.42

rs2076668

GGT7

A

−0.014

1.6E − 05

−0.014

4.0E − 04

−0.014

0.051

−0.005

0.24

rs2921093

PRAG1

T

−0.012

7.3E − 05

−0.012

0.0026

−0.014

0.056

0.003

0.46

Variants identified for eGFR-decline by Gorski et al., but not identified here, Pdecline ≥ 0.05/595

rs60503594

SPATA7

T

−0.009

0.004

−0.008

0.056

−0.003

0.69

−0.020

5.5E − 06

rs13064938

ACVR2B

C

−0.002

0.61

−0.001

0.78

−0.011

0.12

−0.013

3.0E − 03

  1. In the 595-search23, we identified 12 variants for association with eGFR-decline at Bonferroni-corrected significance (Pdecline< 0.05/595 = 8.4 × 10−5; LMM age model RI&RS; UKB 350K dataset, n = 348,275, m = 1,520,382; Supplementary Data 1). Out of these 12 variants, 7 were known (identified previously for eGFR-decline10) and 5 were novel. Two variants identified previously were not identified here (Pdecline ≥ 0.05/595). We compared the 12 + 2 variant results from age model RI&RS in UKB 350K with results from age model RI&RS in UKB 150K, difference model in UKB 150K, and difference model in CKDGen10 (nCKDGen = 343,339, mCKDGen = 686,678), which identified 5/2/0/0 novel variants (4/1/0/0 loci) for eGFR-decline, respectively. Of note, 2 out of 9 variants previously identified for eGFR-decline in CKDGen had been detected at Pdecline < 5 × 10−8 (1 locus, UMOD/PDILT); the others were derived from searching a set of pre-selected variants judged at Bonferroni-corrected level (details in Supplementary Table 5). Shown are effect estimates (betadecline) and P values for eGFR-decline (Pdecline).
  2. SNPID = variant identifier on GRCh37, Locus = nearest gene, EA = effect allele (cross-sectionally eGFR-lowering allele), betadecline and Pdecline = genetic effect and P value for eGFR-decline.
  3. For the following SNPs identified for eGFR-decline by Gorski et al., a proxy variant is shown that was among the 595 SNPs: rs13334589 (proxy for rs34882080, r2 = 0.99), rs10224002 (proxy for rs10254101, r2 = 0.99), rs13064938 (proxy for rs13095391, r2 = 0.84), rs60503594 (proxy for rs1028455, r2 = 0.94), rs1145084 (proxy for rs2453533, r2 = 0.99), and rs28817415 (proxy for rs9998485, r2 = 0.49).
  4. abetas from the CKDGen summary statistics were multiplied by (−1) to align direction. The loci are labeled by the nearest gene of the region lead variant.